Irish campaigners are calling for an independent inquiry into the licensing of a common epilepsy drug linked to birth defects. Read MoreKaren Keely, chairperson of the Organisation for Anti-Convulsant Syndrome (OACS) Ireland made the call as major report was published in the UK. “Thousands of families impacted by sodium valproate in the UK will be feeling a range of emotions this morning. “OACS Ireland members are caring for children, many of which are now adults, with serious irrevocable disabilities and the most complex of needs. “An independent inquiry is now paramount here in Ireland as the only vehicle that can provide answers to the many questions families have regarding the historical use of the drug in Ireland.

Source: Irish Independent July 08, 2020 10:41 UTC